Research Article
Characterization of Clinical Isolates of Enterococci with Special Reference to Glycopeptide Susceptibility at a Tertiary Care Center of Eastern Nepal
Table 3
Antimicrobial resistance patterns among enterococcal species (N (%)).
| | Antibiotics | E. avium (n = 1) | E. cecorum (n = 1) | E. dispar (n = 1) | E. durans (n = 2) | E. faecalis (n = 42) | E. faecium (n = 41) | E. raffinosus (n = 3) | Total (n = 91) |
| | Penicillin | 1 (100) | 0 | 0 | 0 | 7 (16.7) | 28 (68.3) | 1 (33.3) | 37 (40.7) | | Ampicillin | 1 (100) | 0 | 0 | 0 | 7 (16.7) | 27 (65.9) | 1 (33.3) | 36 (39.5) | | Vancomycin | 1 (100) | 0 | 0 | 0 | 11 (26.2) | 7 (17.1) | 0 | 19 (20.9) | | Teicoplanin | 0 | 0 | 0 | 0 | 0 | 4 (9.8) | 0 | 4 (4.4) | | Ciprofloxacin | 1 (100) | 0 | 0 | 0 | 27 (64.3) | 28 (68.3) | 0 | 56 (61.5) | | Chloramphenicol | 0 | 0 | 0 | 0 | 14 (33.3) | 7 (17.1) | 0 | 21 (23.1) | | High-level gentamicin | 0 | 0 | 0 | 0 | 5 (11.9) | 12 (29.3) | 0 | 17 (18.7) | | Linezolid | 0 | 0 | 0 | 0 | 0 | 2 (4.9) | 0 | 2 (2.2) | | Nitrofurantoin | 0 | 0 | 0 | 0 | 3 (10.3) | 7 (25.9) | 0 | 10 (17.9)1 |
|
|
1Only urinary isolates were tested against nitrofurantoin, and 17.9% (10/56) strains were resistant to it.
|
